1-12 of 12
Stefan Aebi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer

Manuela Rabaglio, Daniel Dietrich, Bernhard Scheibe, Thomas Ruhstaller, Franco Nole, Serenella Eppenberger, Christian Oehlschlegel, Dagmar Hess, Christoph Mamot, Elisabetta Munzone, Bernhard Pestalozzi, Stefan Aebi, Marcus Vetter, Beat Thuerlimann, Roger von Moos, Khalil Zaman, Olivia Pagani
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P4-01-25.
https://doi.org/10.1158/1538-7445.SABCS22-P4-01-25
Published: 01 March 2023
View article titled, Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer
Journal Articles

Abstract P3-05-28: Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER+) breast cancer: a retrospective analysis of the SOLE trial

Edoardo Isnaldi, François Richard, Giuseppe Marano, Patrizia Boracchi, Marion Maetens, Giuseppe Floris, Guy Jerusalem, Andrea Gombos, Alastair M. Thompson, Erika Hitre, Stefan Aebi, Marco Colleoni, Patrizia Dell’Orto, Roswitha Kammler, Patrick Neven, Giuseppe Viale, Meredith Regan, Elia Biganzoli, Christine Desmedt
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-05-28.
https://doi.org/10.1158/1538-7445.SABCS22-P3-05-28
Published: 01 March 2023
View article titled, Abstract P3-05-28: Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER+) breast cancer: a retrospective analysis of the SOLE trial
Journal Articles

Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program

Danielle B. Zakon, Coralie Poncet, Fatima Cardoso, Neven Anouk, Vicente Valero, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Judith Fraser, Carmela Caballero, Ingrid A. Hedenfalk, Larissa A. Korde, Barbro Linderholm, John WM Martens, Lavinia P. Middleton, Melissa Murray, Catherine M. Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Melanie Beauvois, Peggy Porter, Carolien P. Schroder, Isabel T. Rubio, Kathryn Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien HM van Deurzen, Elise van Leeuwen-Stok, Joanna M. Vermeij, John MS Bartlett, Antonio C. Wolff, Sharon H. Giordano, W. Fraser Symmans
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD6-11.
https://doi.org/10.1158/1538-7445.SABCS22-PD6-11
Published: 01 March 2023
View article titled, Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
Journal Articles

Abstract OT-26-02: Phase III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients with hormone receptor-positive / HER2-negative resected isolated locoregional recurrence of breast cancer - The POLAR Trial

Elisabetta Munzone, Stefan Aebi, Noelia Martínez Jañez, Uwe Güth, Meritxell Bellet, Barbara Pistilli, Marija Balic, Heidi Roschitzki-Voser, Meredith M Regan
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-26-02.
https://doi.org/10.1158/1538-7445.SABCS20-OT-26-02
Published: 15 February 2021
View article titled, Abstract OT-26-02: Phase III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients with hormone receptor-positive / HER2-negative resected isolated locoregional recurrence of breast cancer - The POLAR Trial
Journal Articles

Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)

Guy Jerusalem, Subrina Farah, Jacquie Chirgwin, Stefan Aebi, Per Karlsson, Patrick Neven, Erika Hitre, Marie-Pascale Graas, Edda Simoncini, Claus Kamby, Alastair Thompson, Sibylle Loibl, Joaquín Gavilá, Katsumasa Kuroi, Christian Marth, Bettina Müller, Seamus O'Reilly, Andrea Gombos, Thomas Ruhstaller, Harold Burstein, Manuela Rabaglio, Barbara Ruepp, Giuseppe Viale, Richard D Gelber, Alan S Coates, Angelo Di Leo, Aron Goldhirsch, Meredith Regan, Marco Colleoni
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-12-01.
https://doi.org/10.1158/1538-7445.SABCS19-P5-12-01
Published: 15 February 2020
View article titled, Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)
Journal Articles

Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations

Jane Bayani, Coralie Poncet, Cheryl Crozier, Quang M Trinh, Megan Hopkins, Aime Lambert Uwimana, Tammy Piper, Carrie Cunningham, Monika Sobol, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Florentine Hilbers, Ingrid Hedenfalk, Larissa Korde, Barbro Linderholm, John Martens, Lavinia Middleton, Melissa Murray, Catherine Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Aleksandra Peric, Peggy Porter, Carolien Schröder, Isabel T Rubio, Kathryn J Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien HM van Deurzen, Elise van Leeuwen-Stok, Joanna Vermeij, Eric Winer, Lincoln D Stein, Sharon H Giordano, Fatima Cardoso, John MS Bartlett
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-10-03.
https://doi.org/10.1158/1538-7445.SABCS19-P4-10-03
Published: 15 February 2020
View article titled, Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations
Journal Articles

Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program

Fatima Cardoso, John Bartlett, Leen Slaets, Carolien van Deurzen, Elise van Leewen-Stok, Peggy Porter, Barbro Linderholm, Ingrid Hedenfalk, Carolien Schroder, John Martens, Jane Bayani, Christi van Asperen, Melissa Murray, Clifford Hudis, Lavinia Middleton, Joanna Vermeij, Stephanie Peeters, Judith Fraser, Monica Nowaczyk, Isabel Rubio, Stefan Aebi, Catherine Kelly, Kathryn Ruddy, Eric Winer, Cecilia Nilsson, Lissandra Dal Lago, Larissa Korde, Kim Benstead, Danielle Van Den Weyngaert, Oliver Bogler, Theodora Goulioti, Nicolas Dif, Carlo Messina, Konstantinos Tryfonidis, Jan Bogaerts, Sharon Giordano
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): S6-05.
https://doi.org/10.1158/1538-7445.SABCS14-S6-05
Published: 01 May 2015
View article titled, Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program
Journal Articles

Risk assessment of grade 2 breast cancer patients by reliable expression profiling with RNA from formalin-fixed, paraffin embedded tissue

Janine Antonov, Vlad Popovici, Andrea Oberli, Anna Baltzer, Sybille Matthey, Martina Schobesberger, Mauro Delorenzi, Stefan Aebi, Hans Jorg Altermatt, Rolf Jaggi
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 974.
Published: 01 May 2008
View article titled, Risk assessment of grade 2 breast cancer patients by reliable expression profiling with RNA from formalin-fixed, paraffin embedded tissue
Journal Articles

Differential Induction of c-Jun NH2-Terminal Kinase and c-Abl Kinase in DNA Mismatch Repair-proficient and -deficient Cells Exposed to Cisplatin

Alissar Nehmé, Rajasekaran Baskaran, Stefan Aebi, Daniel Fink, Sibylle Nebel, Bruno Cenni, Jean Y. J. Wang, Stephen B. Howell, Randolph D. Christen
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3253–3257.
Published: 01 August 1997
View article titled, Differential Induction of c-Jun NH<sub>2</sub>-Terminal Kinase and c-Abl Kinase in DNA Mismatch Repair-proficient and -deficient Cells Exposed to Cisplatin
Open the PDF for Differential Induction of c-Jun NH<sub>2</sub>-Terminal Kinase and c-Abl Kinase in DNA Mismatch Repair-proficient and -deficient Cells Exposed to Cisplatin in another window
Journal Articles

In Vitro and in Vivo Resistance to Cisplatin in Cells That Have Lost DNA Mismatch Repair

Daniel Fink, Hua Zheng, Sibylle Nebel, Paula S. Norris, Stefan Aebi, Tzu-Ping Lin, Alissar Nehmé, Randolph D. Christen, Martin Haas, Carol L. MacLeod, Stephen B. Howell
Journal: Cancer Research
Cancer Res (1997) 57 (10): 1841–1845.
Published: 01 May 1997
View article titled, <em>In Vitro</em> and <em>in Vivo</em> Resistance to Cisplatin in Cells That Have Lost DNA Mismatch Repair
Open the PDF for <em>In Vitro</em> and <em>in Vivo</em> Resistance to Cisplatin in Cells That Have Lost DNA Mismatch Repair in another window
Journal Articles

The Role of DNA Mismatch Repair in Platinum Drug Resistance

Daniel Fink, Sibylle Nebel, Stefan Aebi, Hua Zheng, Bruno Cenni, Alissar Nehmé, Randolph D. Christen, Stephen B. Howell
Journal: Cancer Research
Cancer Res (1996) 56 (21): 4881–4886.
Published: 01 November 1996
View article titled, The Role of DNA Mismatch Repair in Platinum Drug Resistance
Open the PDF for The Role of DNA Mismatch Repair in Platinum Drug Resistance in another window
Journal Articles

Loss of DNA Mismatch Repair in Acquired Resistance to Cisplatin

Stefan Aebi, Buran Kurdi-Haidar, Robert Gordon, Bruno Cenni, Hua Zheng, Daniel Fink, Randolph D. Christen, C. Richard Boland, Minoru Koi, Richard Fishel, Stephen B. Howell
Journal: Cancer Research
Cancer Res (1996) 56 (13): 3087–3090.
Published: 01 July 1996
View article titled, Loss of DNA Mismatch Repair in Acquired Resistance to Cisplatin
Open the PDF for Loss of DNA Mismatch Repair in Acquired Resistance to Cisplatin in another window